MoneyWorks4Me

Laurus Labs board to consider dividend

08 May 2017 Evaluate

Laurus Labs has informed that a meeting of the Board of Directors of the Company will be held on May 18, 2017, to consider and approve the Audited Financial Results of the Company for the Financial Year ended March 31, 2017 and to recommend Dividend, if any, on Equity Shares for the year ended March 31, 2017. Further, the Company’s trading window for dealing in securities by the Directors and Designated Persons shall be closed from May 11, 2017 to May 20, 2017.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..